214 related articles for article (PubMed ID: 9449637)
21. Corticotropin-releasing hormone stimulates steroidogenesis in mouse Leydig cells.
Huang BM; Stocco DM; Hutson JC; Norman RL
Biol Reprod; 1995 Sep; 53(3):620-6. PubMed ID: 7578686
[TBL] [Abstract][Full Text] [Related]
22. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system.
Battaglia G; Webster EL; De Souza EB
Synapse; 1987; 1(6):572-81. PubMed ID: 2843998
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Lovenberg TW; Liaw CW; Grigoriadis DE; Clevenger W; Chalmers DT; De Souza EB; Oltersdorf T
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):836-40. PubMed ID: 7846062
[TBL] [Abstract][Full Text] [Related]
24. Endotoxin decreases corticotropin-releasing factor receptor 1 messenger ribonucleic acid levels in the rat pituitary.
Aubry JM; Turnbull AV; Pozzoli G; Rivier C; Vale W
Endocrinology; 1997 Apr; 138(4):1621-6. PubMed ID: 9075723
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
[TBL] [Abstract][Full Text] [Related]
26. The cellular mechanisms of corticotropin-releasing hormone (CRH)-stimulated steroidogenesis in mouse Leydig cells are similar to those for LH.
Huang BM; Stocco DM; Norman RL
J Androl; 1997; 18(5):528-34. PubMed ID: 9349751
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function.
Ciampani T; Fabbri A; Isidori A; Dufau ML
Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849
[TBL] [Abstract][Full Text] [Related]
28. Ligand requirements of the human corticotropin-releasing factor-binding protein.
Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
[TBL] [Abstract][Full Text] [Related]
29. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
[TBL] [Abstract][Full Text] [Related]
30. [D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors.
Wei ET; Thomas HA; Price JS; Kishimoto T
Eur J Pharmacol; 1996 Jun; 306(1-3):161-4. PubMed ID: 8813628
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid modulation of corticotropin-releasing factor desensitization in cultured rat anterior pituitary cells.
Ceda GP; Hoffman AR
Endocrinology; 1986 Jan; 118(1):58-62. PubMed ID: 3000748
[TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
[TBL] [Abstract][Full Text] [Related]
33. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
[TBL] [Abstract][Full Text] [Related]
34. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures.
Pozzoli G; Bilezikjian LM; Perrin MH; Blount AL; Vale WW
Endocrinology; 1996 Jan; 137(1):65-71. PubMed ID: 8536643
[TBL] [Abstract][Full Text] [Related]
35. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
[TBL] [Abstract][Full Text] [Related]
36. Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action.
Mauduit C; Goddard I; Besset V; Tabone E; Rey C; Gasnier F; Dacheux F; Benahmed M
Endocrinology; 2001 Jun; 142(6):2509-20. PubMed ID: 11356700
[TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
Dieterich KD; Grigoriadis DE; De Souza EB
Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing factor up-regulates its own receptor gene expression in corticotropic adenoma cells in vitro.
Sakai Y; Horiba N; Sakai K; Tozawa F; Kuwayama A; Demura H; Suda T
J Clin Endocrinol Metab; 1997 Apr; 82(4):1229-34. PubMed ID: 9100600
[TBL] [Abstract][Full Text] [Related]
39. An artificial peptide with corticotropin-releasing factor receptor-2 (CRF-R2) selective properties: the role of primary structure in the induction of signal transduction pathways.
Tellam DJ; Smart D; Qian X; Lovejoy DA
J Pept Res; 2002 Oct; 60(4):215-22. PubMed ID: 12366528
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of corticotropin releasing factor (CRF)-induced adrenocorticotropin (ACTH) secretion in pituitary corticotropic cells by substance P.
Melzig MF; Papsdorf G; Putscher I; Winkler A; Siems WE
Pharmazie; 1998 Aug; 53(8):569-72. PubMed ID: 9741065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
